Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Application of stem cells in human medicine – from basic science research to clinical trials

Advances in Clinical and Experimental Medicine

Adv Clin Exp Med

Call for submissions of an Expression of Interest for an Adv Clin Exp Med Special Collection on

Application of stem cells in human medicine – from basic science research to clinical trials

 

Handling Editors

 

Prof. Bartosz Kempisty (Department of Histology and Embryology, Poznan University of Medical Sciences, Poland; ORCID 0000-0002-6423-686X) bkempisty@ump.edu.pl

Prof. Michal Jeseta (Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, Brno, Czech Republic)

Prof. Paweł Antosik (Department of Veterinary Surgery, Institute of Veterinary Sciences, Nicolaus Copernicus University in Torun, Poland)

 

 

Medicine in the twenty-first century is closely associated with stem cell research, based on advanced in vitro analyzes, the use of model animals, and their application in clinical trials. Experimental research requires understanding the physiological and morphological properties of stem cells and analyzing their ability to divide and differentiate into other cell types. The best-known stem cells are those derived from bone marrow and umbilical cord blood. However, in recent years, stem cells have been discovered in, for example, adipose tissue and Wharton jelly. Stem cells isolated from these tissues, once properly differentiated, are increasingly used for the treatment of bone and neurodegenerative diseases. In recent years, the number of therapies using stem cells has increased significantly. The ability of stem cells to differentiate makes them an increasingly common therapeutic tool in regenerative and reconstructive medicine.

 

Key words:

mesenchymal stem cells, embryonic stem cells, iPSCs, cancer stem cells, cell proliferation and differentiation, small extracellular vesicles, exosomes, omics, animal models, preclinical and clinical trials, regenerative medicine, reconstructive medicine

 

Articles submitted should be related to the topic of stem cells and their use in basic and clinical research. Topics may include:

  • molecular research involving advanced genomic methods
  • tissue and cell research
  • studies on the morphological and physiological properties of stem cells
  • studies on the proliferative and multidirectional differentiation capacity of stem cells
  • studies on model animals
  • use of stem cells in preclinical and clinical research
  • therapies with stem cell
  • stem cells in regenerative and reconstructive medicine
  • stem cells in translational medicine

 

Review articles describing recent achievements in stem cell medicine, as well as original articles will be accepted.

 

Submission process

As a first step, we request submission of an expression of interest with an abstract of original papers outlining the above topics to Adv Clin Exp Med Section Editor: (kempistybartosz@gmail.com)

The Section Editor, together with the Editor-in-Chief, will review all submissions and select those who will be invited to submit a full paper. The submission process will then follow the regular Adv Clin Exp Med online process. All manuscripts will be sent to at least two independent reviewers.

 

Deadlines and fees

 

Submission of expression of interest by March 15, 2023

Call for full paper submission – by April 30, 2023

Submission of full paper by June 30, 2023

 

In case of acceptance, authors will have to pay a fee of 700 EUR to cover publication costs; however for selected authors (outstanding experts) it is possible to reduce or even waive the publication fee.

We are looking forward to a great diversity and a truly global collection of contributions and experiences to take science to the next level worldwide!